LIVE — 15:41 ET
← All Strategies
LOSING

Fda Catalyst

Biotech FDA event plays: volume spike + momentum in pharma/biotech

FDA Catalyst (Biotech Events)

3Y
Total Return
+2.3%
3Y
Sharpe Ratio
-0.28
3Y
Max Drawdown
-15.8%
3Y
Win Rate
47.4%
3Y
Alpha
-22.4%
3Y
Comp. Score *
0.00
Risk Parameters
Max Allocation0.0%
Stop Loss15.8%
Take Profit5.0%
Max DD Tolerance15.8%
Rebalanceweekly
Execution Guidance
Order TypeLimit
Entry RuleBuy 0.5% below market in uptrend.
TimingSAFE TO BUY. *
ScalingEnter in 3 tranches over 1-2 weeks.
Positions — Vol-Adjusted Sizing
SymbolActionVol Stop LossTake ProfitSizeLinks
GILD BUY 27% 18.0% below entry 5.7% above entry 0.0% TVYH
BIIB BUY 31% 20.4% below entry 6.5% above entry 0.0% TVYH
IONS BUY 46% 30.6% below entry 9.7% above entry 0.0% TVYH
ABBV BUY 26% 17.5% below entry 5.5% above entry 0.0% TVYH
JNJ BUY 18% 11.8% below entry 3.7% above entry 0.0% TVYH
XBI BUY 27% 17.6% below entry 5.6% above entry 0.0% TVYH
IBB BUY 21% 14.2% below entry 4.5% above entry 0.0% TVYH
AMGN BUY 27% 17.7% below entry 5.6% above entry 0.0% TVYH
▶ For Passive Investors (Buy & Hold)

This strategy is NOT recommended for passive investing. - Take profit: Take profit at +50%. This strategy is inconsistent — capture gains when available. - Stop loss: Reduce position by 50% at -25% drawdown. Consistency is only 14%. - Exit rule: Review semi-annually. Exit if strategy thesis no longer holds based on fundamental analysis.

Avg 5Y Return
-24.4%
Avg 5Y Sharpe
-0.72
10Y Return
-43.4%
10Y Sharpe
-0.74
HODL Composite
-0.01
Consistency
14%
Suitable for passive
No